Debt-to-equity of CERO THERAPEUTICS HOLDINGS, INC. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CERO THERAPEUTICS HOLDINGS, INC. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • CERO THERAPEUTICS HOLDINGS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -389%, a 433% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CERO THERAPEUTICS HOLDINGS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -389% -316% -433% 30 Sep 2025
Q2 2025 -456% -388% -577% 30 Jun 2025
Q1 2025 -434% -371% -595% 31 Mar 2025
Q4 2024 -342% -286% -512% 31 Dec 2024
Q3 2024 -73% +88% +55% 30 Sep 2024
Q2 2024 -67% +102% +60% 30 Jun 2024
Q1 2024 -62% +118% +65% 31 Mar 2024
Q4 2023 -56% +133% +71% 31 Dec 2023
Q3 2023 -161% -46% -39% 30 Sep 2023
Q2 2023 -169% -51% -43% 30 Jun 2023
Q1 2023 -180% 31 Mar 2023
Q4 2022 -189% 31 Dec 2022
Q3 2022 -115% 30 Sep 2022
Q2 2022 -118% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.